Nancy Long was a gynecological nurse practitioner when she was diagnosed with ovarian cancer. Yet because the symptoms were so vague, she nearly ignored them. “I missed all the signs and symptoms of ...

The city of Laredo marked Ovarian Cancer Awareness Month with a call to action: recognize symptoms, understand genetic risk and seek early detection. Officials and advocates said these steps are vital ...

Since 2023, a rumor has spread online spread that some jobs carried a higher risk of ovarian cancer. For example, one post on X said accounting and hairdressing were two of the jobs linked to a higher ...

Novel drug combinations that improve outcomes, outstanding questions about treatment sequence, and encouraging results in chemotherapy resistant disease are among the ovarian cancer highlights ...

An Ohio mom is opening up about being diagnosed with ovarian cancer after initially thinking she had a sinus infection. In January, Jessica Gilbert, a mom of two from the Cincinnati, Ohio, area, was ...

CURE spoke with Dr. Ryan Kahn of Miami Cancer Institute for Ovarian Cancer Awareness Month. To coincide with the observation of Ovarian Cancer Awareness Month in September, CURE spoke with Dr. Ryan ...

An expert discusses how multidisciplinary collaboration can be enhanced through shared knowledge of available drugs and biomarkers among oncologists and pathologists, standardized interpretation ...

Genetic susceptibility accounts for 20% of ovarian cancer risk, and risk-reducing bilateral salpingectomy remains the gold standard for prevention. In this study, about 24% of patients with high-grade ...

Rucaparib maintenance therapy provided consistent benefits across all subgroups of patients grouped by prognostic factors of their homologous recombination deficiency-negative ovarian cancer tumors.

New research by Wistar Institute scientists shows how targeting a cleft in the retinoblastoma protein can kill tumor-protecting macrophages in ovarian cancer. The discovery provides a novel ...

A new research paper was published in Volume 16 of Oncotarget on September 22, 2025, titled "Loss of Trp53 results in a hypoactive T cell phenotype accompanied by reduced pro-inflammatory signaling in ...